Clinical trial
A Phase II Randomized, Double Blind, Placebo-Controlled Study of Recombinant Human Relaxin in Patients With Decompensated Congestive Heart Failure
NCT00406575 is registered in ClinicalTrials.gov with Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Randomized, Double Blind, Placebo-Controlled Study of Recombinant Human Relaxin in Patients With Decompensated Congestive Heart Failure
- Lead sponsor
- Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- November 30, 2006
- Completion date
- January 31, 2007
- Enrollment
- 11 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
congestive heart failure (chf)